These findings suggest that WYJDTLF ameliorates podocyte injury through modulation of the JAML/SIRT1 pathway, potentially by restoring lipid homeostasis and improving cellular energy metabolism in diabetic nephropathy. The gene discussed is JAML; the disease is diabetic kidney disease.